|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, December 07, 2017 ) According to the report Latin America HIV Diagnostics Market, published by Market Data Forecast, the global market is projected to reach USD 565.26 million by 2021, at a CAGR of 10.2% from 2016 to 2021.
HIV Market spreads through exchange of fluids with some infected individual, for example, blood exchange or imparting needles to somebody who is HIV infected. Additionally, HIV can spread from infected mother to child during pregnancy. Here are some of the symptoms of HIV disease are slight fever, weakness, swollen glands, cerebral pains and muscle hurts. Integrase inhibitors section is expected to be the rapid growing class of antiretroviral medications owing to the normal dispatch of extra integrase inhibitors by major players, for example, Gilead Sciences, In., and Merck and Co., Inc.
Get accurate market forecast and analysis on the Latin America HIV Diagnostics Market. Request a sample to stay up-to-date on the main trends affecting this market: http://www.marketdataforecast.com/market-reports/latin-america-hiv-diagnostics-market-2149/request-sample
HIV endemic has had devastating economic, social, health and psychological impacts over the years affecting millions of households in a significant manner over the last decade. Despite the concrete efforts from authorities and various philanthropic institutions, the numbers are still on an upward trend with a total of 33.3 Million HIV victims across the world
Latin America HIV Diagnostics Market: Drivers & Restraints
Major factors driving the market are, the technological advancement of disease diagnostic tests, and the foreseen improvement and commercialization of novel, regulatory authorities approved POC and rapid CD4, p24 antigen and EID tests; it is expected that all the major regional market segments will witness an expansion in market demand over the forecast period. There is a need to increase in introducing easily accessible, efficient robust diagnostics tests. Because of the financial resource constrained settings in a huge share of the disease affected regions it is as yet not feasible to perform the current, complex screening, staging and monitoring tests. This is either because of the absence of adequate testing labs or an absence of prepared clinical technicians capable of performing the tests. These limitations of laboratory based testing are a catalyst to the improvement of convenient and simple to execute point of care, rapid tests.
Get a comprehensive overview of the Latin America HIV Diagnostics Market: http://www.marketdataforecast.com/market-reports/latin-america-hiv-diagnostics-market-2149/
Latin America HIV Diagnostics Market: Segmentation
By Product
Introduction
Consumables
o Assays and Kits &Reagents
o Other Consumables
Software & Services
Y-o-Y Growth Analysis, By Product
Market Attractiveness Analysis, By Product
Market Share Analysis, By Product
By Type
Introduction
Antibody Tests
o HIV Screening Tests
o HIV-1 Antibody Confirmatory Tests
o HIV-2 & Group O Diagnostic Tests
Viral Identification Tests
o p24 Antigen Test
o Qualitative PCR Tests
o Viral Culture
CD4 Testing
Viral Load testing
Early Infant Diagnostics
Y-o-Y Growth Analysis, By Type
Market Attractiveness Analysis, By Type
Market Share Analysis, By Type
By End User
Introduction
Diagnostic Laboratories
Hospitals
Blood Banks
Home Care Settings
Other End Users
Y-o-Y Growth Analysis, By End User
Market Attractiveness Analysis, By End User
Market Share Analysis, By End User
From simple data collation through secondary and primary research to ad-hoc research requests relating to specific information, we provide our services via customization. Get customization at http://www.marketdataforecast.com/market-reports/latin-america-hiv-diagnostics-market-2149/customize-report
Latin America HIV Diagnostics Market: Overview
The leading business intelligence provider GBI Research has released its latest research report, entitled HIV Diagnostics Market to 2019 Limited Pipeline Efficacy Improvement, Patent Expirations and Stringent Healthcare Spending to Suppress Market Growth. The report provides insights into the HIV (Human Immunodeficiency Virus) therapeutics market including market forecasts up to 2019. It provides an in-depth analysis of the major marketed products, as well as insights into the HIV therapeutics R&D pipeline.
Viral Load testing and CD4 testing also accounted for a considerable share of the market in past. There is a prevalent in the market for the development of these tests which will make them more sensitive, rapid in nature and portable to the point of care to enhance their market usability and accessibility in resource limited HIV affected regions. It is expected that during the forecast period a number of novel point of care HIV diagnostic products will be commercialized which are currently under clinical development and in product pipelines of key market players. This increase in the range of products s expected to fuel the growth of this market over the forecast period.
Latin America HIV Diagnostics Market: Region-wise Outlook
Based on geography the market is analysed under various regions namely, Mexico, Argentina and Brazil. Mexico accounts for highest share in the market and is expected to continue its dominance over the forecast period.
Key Questions Answered
What is the current and future HIV Diagnostics Market outlook in Latin America? What trends are affecting the Latin America market?
What is the competitive landscape and market share of major players in the HIV Diagnostics space in Latin America?
What are the key, high growth markets that Latin America HIV Diagnostics manufacturers should expand into? Which market segments are growing the fastest?
What are the unmet needs with the HIV Diagnostics currently on the market? How will emerging technologies fulfil these unmet needs?
What is physician perception and market outlook of HIV Diagnostics?
What are the challenges and barriers that have hindered widespread adoption of HIV Diagnostics?
North America HIV Diagnostics Market: Key Players
Some of the major Companies dominating the market, by their products and services include AbbVie, Inc., Bristol-Myers Squibb Company, Merck and Co., Inc., and Boehringer Ingelheim GmbH. Gilead Sciences, Inc. was the pioneer in HIV-1 therapeutics sector by considering market share and medication portfolio, took after by ViiV Healthcare in 2015. What's more, in the coming years other little players are required to enter this part with their pipeline drugs.
Reasons to buy North America HIV Diagnostics Market Report:
Global, regional and country-level analysis and forecasts of the study market; providing Insights on the geographical areas in which this industry is prospering
Segment-level analysis on basis of product type, application, colour along with market size forecasts and y-o-y estimations to detect key areas of industry growth in detail
Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
Study of macro and micro environmental factors that affect the market presented in an extensive strategic analyses section containing PESTLE and Porters Five Forces Analyses
A comprehensive listing of key market players along with company overview, product portfolios, key financial information (subjected to availability), SWOT analysis and Analyst overview to study and sustain the market environment
Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
Expertly devised Market Outlook along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
Checkout other related studies in the Diagnostics Segment:
Latin America In-Vitro Diagnostics Market: http://www.marketdataforecast.com/market-reports/latin-america-in-vitro-diagnostics-market-150/
Latin America Genetic Testing Market: http://www.marketdataforecast.com/market-reports/latin-america-genetic-testing-market-40/
Latin America Head and Neck Cancer Diagnostics Market: http://www.marketdataforecast.com/market-reports/latin-america-head-and-neck-cancer-diagnostics-market-57/
About Market Data Forecast:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options.
For more information, kindly visit, www.marketdataforecast.com
Visit Market Data Forecast Blog @ http://www.marketdataforecast.com/blog/
View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases
Market Data Forecast
Abhishek
+1-888- 702-9626
abhishek@marketdataforecast.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
